Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.
Dawkowanie
Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Moc
Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Wielkość opakowania
Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Postać
Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Źródło
European Medicines Agency
Profil bezpieczeństwa
Przeciwwskazania
Skutki uboczne
Skanuj ten kod QR, aby szybko uzyskać dostęp do tej strony na swoim urządzeniu mobilnym.